Mesenchymal Stromal Cells
Living cells capable of sensing their surrounding environment, interacting with immune cells and releasing soluble and vesicular signals.
CELLMEX Scientific Library
Mechanisms of Action
A mechanism of action describes how a biological intervention interacts with cells, tissues or molecular pathways to produce a measurable biological effect. In regenerative medicine, these mechanisms are frequently multidimensional, context-dependent and influenced by the manufacturing process.
Scientific Definition
Biological effect is produced through interacting pathways
A mechanism of action links a biological product with the molecular, cellular or tissue-level processes that may explain its observed effect.
Regenerative medicine products frequently contain complex cellular or cell-derived components. Their activity may therefore depend on several related mechanisms rather than one isolated target.
For mesenchymal stromal cells, current research places substantial emphasis on transient signalling, immunological interaction and secretion of soluble and vesicular factors rather than routine permanent engraftment or direct replacement of damaged tissue.
Biological Platforms
Different products act through different biological components
Cellular and cell-free preparations should not be assumed to share an identical mechanism of action, even when they originate from the same source cells.
MSC Secretome
The combined soluble and vesicular biological output released by cultured MSC populations under defined conditions.
Extracellular Vesicles
Membrane-enclosed particles capable of interacting with recipient cells and carrying proteins, lipids and nucleic acids.
Conditioned Media
Culture medium containing cell-derived factors together with residual media and process-related components.
Principal Mechanisms
Proposed pathways of biological activity
The relative importance of each mechanism depends on the biological product, dose, administration route, recipient tissue and disease environment.
Paracrine Signalling
Cells release biological signals that influence nearby or distant recipient cells without necessarily becoming part of the target tissue.
- Cytokines and chemokines
- Growth and trophic factors
- Lipid mediators
- Extracellular vesicles
Immunomodulation
MSCs and their released factors may interact with innate and adaptive immune pathways.
- T-cell responses
- B-cell activity
- Macrophage phenotype and function
- Dendritic and natural-killer-cell activity
Extracellular-Vesicle Communication
Extracellular vesicles may bind to recipient-cell surfaces, undergo endocytic uptake or interact with cellular membranes.
- Receptor interaction
- Vesicle internalisation
- Delivery of selected molecular cargo
- Modification of intracellular signalling
Trophic and Survival Support
Secreted signals are studied for their potential to support cellular survival and stress responses.
- Anti-apoptotic signalling
- Cellular stress modulation
- Endogenous repair-cell support
- Tissue-homeostasis signalling
Angiogenic and Vascular Signalling
Selected factors may influence endothelial cells, vascular stability and new-vessel-associated signalling in experimental systems.
- Endothelial-cell migration
- Vascular growth signalling
- Microvascular support
- Tissue-perfusion research
Extracellular-Matrix Modulation
Cellular and secreted products may influence the structure and turnover of the tissue environment.
- Matrix synthesis
- Matrix-degrading enzymes
- Fibrotic signalling
- Cell–matrix interaction
Recruitment of Endogenous Cells
Chemotactic signals may influence the migration or activity of resident progenitor, immune, endothelial or repair-associated cells.
Direct Cellular Interaction
Living MSCs may communicate through physical contact, receptor–ligand interactions and exchange of biological material with neighbouring cells.
Cellular Response Pathway
From administration to biological response
This pathway is a general scientific model. Actual biodistribution and response vary by product and administration route.
Administration
A cellular or cell-derived preparation is delivered by a defined local or systemic route.
Distribution
Cells, vesicles or soluble factors distribute according to their size, formulation, route and biological environment.
Environmental Sensing
Living cells and recipient tissues respond to inflammatory, hypoxic, mechanical and molecular signals.
Molecular Interaction
Receptors, soluble mediators, cell contact or vesicle uptake influence intracellular pathways.
Measurable Response
Biological effects may be assessed through biomarkers, cellular assays, imaging, function or clinical outcomes.
Context-Dependent Activity
Mechanism of action is influenced by the product and recipient
Two preparations carrying the same general label may differ substantially in biological activity.
Cell and Tissue Source
Bone-marrow, adipose and perinatal-tissue cells may produce different molecular and functional profiles.
Donor and Passage
Donor characteristics, cellular age, expansion history and senescence may alter biological activity.
Culture Conditions
Media, supplements, oxygen tension, confluence and three-dimensional culture may affect cellular signalling.
Priming and Preconditioning
Exposure to inflammatory, hypoxic, mechanical or other signals may change the secretory response.
Processing and Storage
Isolation, concentration, cryopreservation, filtration and freeze–thaw conditions may affect composition and function.
Recipient Environment
Disease stage, inflammation, medication, immune status and tissue condition may influence the biological response.
Potency and Functional Assessment
Mechanistic claims should be linked to measurable function
A potency assay should measure a biological activity relevant to the intended mechanism and proposed clinical use of the product.
Immunomodulatory Assays
Evaluation of effects on selected immune-cell activation, proliferation, cytokine production or phenotype.
Angiogenic Assays
Assessment of endothelial-cell migration, survival, network formation or related vascular responses.
Cytoprotection Assays
Measurement of recipient-cell survival under inflammatory, oxidative, metabolic or other stress.
Matrix-Related Assays
Evaluation of matrix production, degradation, fibrosis-related signalling or tissue-remodelling activity.
EV Uptake or Activity Assays
Assessment of vesicle interaction with recipient cells and a defined downstream biological response.
Assay Matrix
Complex products may require several complementary assays rather than one test to represent overall biological activity.
Translational Research
Mechanisms under active investigation
Musculoskeletal Biology
Paracrine, inflammatory, vascular and matrix-related mechanisms in cartilage, tendon, bone and joint environments.
Immune-Mediated Disease
Interaction with immune-cell populations, inflammatory signalling and tissue-specific immune environments.
Neurological Biology
Neuroinflammatory, trophic, vascular and extracellular-vesicle-mediated signalling.
Wound and Skin Repair
Fibroblast, epithelial, angiogenic and matrix-remodelling responses in experimental healing models.
Organ Injury
Immunological, anti-apoptotic and vascular mechanisms in pulmonary, renal, hepatic and cardiac research models.
Product Engineering
Priming, culture design, tissue direction, fractionation and formulation intended to produce a more defined biological function.
Clinical and scientific qualification
Mechanisms observed in cell culture or animal models do not automatically establish safety, efficacy or an appropriate dose in human patients.
MSCs, extracellular vesicles, secretome and conditioned-media preparations should not be treated as interchangeable products. Their composition, biodistribution and biological activity may differ substantially.
A proposed mechanism should be supported by product-specific characterisation, functional testing and evidence relevant to the intended clinical indication.
Regenerative medicine interventions should not be represented as established cures or as guaranteed methods of replacing damaged organs, neurons, cartilage or other tissues without appropriate human clinical evidence.
The CELLMEX Approach
Mechanism-led development and clinical translation
Define the Biological Product
Establish cell source, composition, manufacturing process, formulation and relevant quality attributes.
Identify the Proposed Mechanism
Determine which molecular or cellular pathway is scientifically relevant to the intended use.
Develop Functional Testing
Select assays capable of measuring the proposed biological activity in a reproducible manner.
Connect Mechanism to Clinical Evidence
Evaluate whether biological activity corresponds with meaningful safety, biomarker, functional or clinical outcomes.
Selected Scientific References
Mechanistic and translational literature
Alvites R, et al. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential.
Pharmaceutics. 2022;14(2):381.
View publicationSong N, et al. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.
Cell and Tissue Research. 2020.
View publicationMartin-Rufino JD, et al. Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles.
Frontiers in Immunology. 2019;10:2729.
View publicationvan Niel G, D’Angelo G, Raposo G. Shedding Light on the Cell Biology of Extracellular Vesicles.
Nature Reviews Molecular Cell Biology. 2018;19:213–228.
View publicationFerreira JR, et al. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Frontiers in Immunology. 2018;9:2837.
View publicationKusuma GD, Carthew J, Lim R, Frith JE. Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling.
Stem Cells and Development. 2017;26(9):617–631.
View publication
Scientific Information
Explore CELLMEX translational research
Physicians, researchers and institutions may request information concerning MSC biology, extracellular vesicles, secretome technologies, functional assays and research collaboration.